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Abstract
Background The Dutch Cancer Society proposed that the
interval between diagnosis and start of treatment should be
less than 15 working days. The purpose of this study was to
determine whether the interval from diagnosis to treatment
for patients with colorectal cancer (CRC) shortened between
2005 and 2008 in hospitals in southern Netherlands.
Methods Patients with CRC diagnosed in six hospitals in
southern Netherlands during January to December in 2005
(n = 445) and January to July in 2008 (n = 353) were
included. The time between diagnosis and start of treatment
was assessed, and the proportion of patients treated within
the recommended time (\15 working days) was calculated.
Results The time to treatment for colon cancer patients was
13 working days in 2005 and 17 working days in 2008. For
rectal cancer patients, the median time to preoperative radio-
therapy was 28 working days in 2005 and 30 working days in
2008, and the median time to surgical treatment for rectal
cancer patients was 26 working days in 2005 and 18 working
days in 2008. Time to treatment did not shorten between 2005
and 2008 for colon and rectal cancer patients, except for rectal
cancer patients who underwent surgery as initial treatment in
patients aged[70 years and those with stage I disease. Sub-
stantial variation was seen among hospitals.
Conclusions Time to treatment for patients with CRC in
southern Netherlands did not shorten between 2005 and
2008. The time to treatment should be reduced to meet the
advice of the Dutch Cancer Society.
Introduction
Colorectal cancer (CRC) is the third most frequent cancer
in The Netherlands, with more than 11,000 new cases
annually and a lifetime risk of more than 5% [1]. Over a
period of more than two decades, a clear improvement in
survival of patients with CRC was attained by earlier
detection due to a lower barrier for endoscopy, better
staging, improved surgery, and combined-modality treat-
ment [2, 3]. Most of these patients still present with
symptomatic disease because population-based screening
has not yet been implemented in The Netherlands.
Since 2000, guidelines in Dutch specialized care
(Treeknormen) indicate that the time from diagnosis to the
start of clinical treatment should be within 35 days for 80%
of patients and within 49 days for all patients [4]. For
patients with life-threatening disease including cancer, a
Dutch Cancer Society working group (consisting of medical
specialists, social medicine specialists, and an economist)
proposed in 2005 that the interval between diagnosis and
treatment of cancer should be less than 15 working days [5],
more or less in agreement with several other countries,
including Denmark and the United Kingdom [6, 7]. To
decrease the interval between diagnosis and treatment a
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project called Sneller Beter (Getting Well Faster) was started
in November 2003 in The Netherlands funded by the
Ministry of Health [8].
It is arbitrary to what degree treatment delay contributes
to disease stage at presentation [9]. However, a longer time
interval from diagnosis to treatment might have a negative
effect on the patient’s psychological well-being [10, 11],
which may affect the physical condition of the patient.
Symptoms or clusters of symptoms might affect the inter-
val between diagnosis and treatment as symptoms are
related to the severity of the disease [12].
The purpose of this study was to determine whether the
time from diagnosis to treatment for patients with CRC
shortened between 2005 and 2008 in hospitals in southern
Netherlands.
Methods
Data collection
Population-based data from the Eindhoven Cancer Registry
(ECR), which is maintained by the Comprehensive Cancer
Centre South, were used. The ECR collects data for all
patients newly diagnosed with cancer in the southern part of
The Netherlands. The ECR serves 10 community hospitals, 6
pathology departments, and 2 radiotherapy institutes in an
area comprising 2.3 million inhabitants. Information on
diagnosis, staging, and treatment is obtained routinely from
the medical records [13]. In addition, information on co-
morbidity has been collected since 1993 based on the
Charlson Co-morbidity Index [14]. Socioeconomic status,
based on individuals’ fiscal data on the economic value of the
home and household income, is provided at an aggregated
level for each postal code [15]. The quality of the data is high
because of thorough training of the registrars and comput-
erized consistency checks at regional and national levels.
Completeness is estimated to be at least 95% [16].
Study population
For the present study, 445 patients with primary CRC
diagnosed in 2005 and 353 patients with primary CRC
diagnosed between January 1, 2008 and August 1, 2008 in six
hospitals in southern Netherlands were included. All patients
underwent resection of their tumor or radiotherapy treatment
within 6 months after diagnosis. Patients with previous cancer
(n = 137) or who underwent acute resection (n = 34) were
excluded. Colon cancer was defined as C18, rectal cancer as
C19-C20 according to the International Classification of Dis-
eases for Oncology 03 [17]. Tumor localization was catego-
rized into anatomic subsites: proximal colon, consisting of the
cecum, appendix, ascending colon, hepatic flexure, transverse
colon, and splenic flexure (C18.0–C18.5); distal colon, con-
sisting of descending colon and sigmoid (C18.6–C18.7); colon
not otherwise specified (NOS) (C18.8, C18.9); and rectum,
consisting of rectosigmoid and rectum (C19.9, C20.9).
The TNM stage was based on the pathological stage and
the clinical stage when the pathological stage was
unknown, as clinical stage alone was unknown for many
patients. Date of diagnosis was defined as the date of his-
tological verification of the tumor. Time to treatment was
defined as the time interval between the histologically
confirmed diagnosis and the start of initial treatment, which
is surgical resection, except for those undergoing preop-
erative radiotherapy. Nonelective surgical treatment was
defined as surgery and diagnosis on the same day. The
starting date of radiotherapy was obtained from both
radiotherapy institutes in the ECR region.
Additional data were extracted from the medical records
by one of the authors (L.N.S) and a research assistant,
under supervision of the treating physicians. This included
date of imaging procedures and date of surgery. Imaging
procedures included thoracic radiography, abdominal
ultrasonography (US), abdominal computed tomography
(CT), and magnetic resonance imaging (MRI). For patients
diagnosed in 2005, symptoms were registered based on the
medical record, with a maximum of four symptoms per
patient. An early-stage cluster was created that contained
patients who had rectal blood loss, mucus in stool, or no
complaints. Data about radiotherapy including starting date
of treatment and date of registration at the institute were
obtained from the radiotherapy institutes.
Statistical analysis
Time between the diagnosis of CRC and imaging proce-
dures, surgery, and radiotherapy was assessed. Variation in
time between diagnosis and treatment was determined per
age group (\70 years and C70 years), stage, socioeco-
nomic status, co-morbidity, and hospital. The Mann–
Whitney test was conducted to test whether the time
between diagnosis and treatment differed markedly
between predefined groups of patients. Furthermore, the
time between diagnosis and treatment was described for
symptoms. The proportion of patients who were treated
within the time recommended by the Dutch Cancer Society
advice were compared between 2005 and 2008.
Survival time was defined as the time from diagnosis to
death or January 1, 2009 for the patients who were still
alive. A crude 5-year survival rate was calculated, and a
log-rank test was carried out to compare survival propor-
tions. A multivariable proportional hazards regression
analysis was used to discriminate independent risk factors
for death (SAS system 9.1; SAS Institute, Cary, NC, USA).
A value of p \ 0.05 was considered statistically significant.
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Results
Colon cancer patients diagnosed in 2005 and 2008 were
similar in age, socioeconomic status, co-morbidity, stage,
and timing of surgical treatment. However, those diag-
nosed in 2008 more often had a tumor located in the distal
colon, and the pathologic lymph node status differed. The
mean age of patients with colon cancer was 71 years (range
36–91 years), and almost half them suffered from one or
more co-morbid conditions. Most of the patients had a T3
tumor, and 16% of those diagnosed in 2005 and 11%
diagnosed in 2008 had metastatic disease at diagnosis
(Table 1). Most of the rectal cancer patients underwent
preoperative radiotherapy. In 2005 the age of rectal cancer
Table 1 Descriptives of the
study population: colon cancera
NOS Not otherwise specified
a No patients with previous
cancer
b Excluding hypertension, as it
is generally a minor
co-morbidity
c If the pathologic stage was
unknown, the clinical stage was
used
d Nonelective was defined as
surgery on the same day as the
diagnosis
* p \ 0.05 between 2005 and
2008; ** p \ 0.0001 between
2005 and 2008
Parameter 2005 (n = 177) 2008 (n = 219)
No. % No. %
Age (years), mean and range 70 (72–89) 71 (38–94)
Sex (male) 92 52 110 50
Socioeconomic status
Low 42 24 50 23
Intermediate 61 35 84 38
High 64 36 68 31
Institutionalized 7 4 8 4
Unknown 3 2 9 4
Co-morbidityb
None 72 41 106 48
One 51 29 49 22
Two or more 42 24 55 25
Unknown 12 7 9 4
Tumor site
Proximal colon 122 69 122 56**
Distal colon 52 29 96 43
Colon (other/NOS) 3 2 1 1
Pathological T stagec
1 9 5 17 8
2 24 14 32 15
3 115 65 132 60
4 27 15 29 13
Unknown 2 1 9 4
Pathologic N stage
N0 103 58 113 52*
N? 70 40 90 41
Unknown 4 2 16 7
M stage
0 126 71 172 79
1 29 16 24 11
Unknown 22 12 23 11
TNM stage 29 16 39 18
I
II 66 37 77 35
III 51 29 72 33
IV 29 16 24 11
Unknown 2 1 7 3
Timing of surgical treatment
Elective 128 72 157 72
Nonelectived 49 28 62 28
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patients who did and those who did not undergo preoper-
ative radiotherapy was similar, whereas in 2008 those who
underwent preoperative radiotherapy were younger (65 vs.
74 years). In 2008 almost none who underwent radiother-
apy had a tumor in the rectosigmoid, whereas 8% did so in
2005. Socioeconomic status, co-morbidity, and stage were
similar for rectal cancer patients between 2005 and 2008
(Table 2).
For patients with colon cancer the median time to
treatment was 13 working days in 2005 and 17 working
Table 2 Descriptives of the
study population: rectal cancera
PreopRT Preoperative
radiotherapy
a No patients with previous
cancer
b Excluding hypertension, as it
is generally a minor co-
morbidity
c If the pathologic stage was
unknown, the clinical stage was
used
d Nonelective was defined as
surgery on the same day as the
diagnosis
* p \ 0.05 between 2005 and
2005; ** p \ 0.0001 between
2005 and 2008
Parameter 2005 (n = 186) 2008 (n = 134)
No preop RT
(n = 46)
Preop RT
(n = 140)
No preop RT
(n = 27)
PreopRT
(n = 107)
No. % No. % No. % No. %
Age (years), mean
and range
69 (36–85) 68 (33–90) 74 (58–94)* 65 (31–93)
Sex (male) 23 50 76 55 21 78* 63 59
Socioeconomic status
Low 8 17 27 19 6 22 22 20
Intermediate 12 26 59 42 6 22 49 46
High 20 43 45 32 11 41 34 32
Institutionalized 5 11 7 5 2 7 1 1
Unknown 1 2 2 1 2 7 1 1
Co-morbidityb
None 27 59 65 46 12 44 57 53
One 12 26 40 29 8 30 24 22
Two or more 6 13 24 17 7 26 22 21
Unknown 1 2 11 8 0 0 4 4
Tumor site
Rectosigmoid 19 41 11 8 6 22** 2 2**
Rectum 27 59 129 92 21 78 105 98
Pathologic T stagec
1 5 11 4 3 5 19 5 5
2 14 30 46 33 8 30 32 30
3 25 54 73 52 14 52 50 47
4 2 4 10 7 0 0 8 7
Unknown 0 0 7 5 0 0 12 11
Pathologic N stage
N0 21 46 88 63 12 44 62 58
N? 20 43 45 32 9 33 31 29
Unknown 5 11 7 5 6 22 14 13
M stage
0 33 72 106 76 22 81 84 79
1 7 15 22 16 5 19 11 10
Unknown 6 13 12 8 0 0 12 11
TNM stage
I 15 33 42 30 12 44 27 25
II 10 22 37 26 6 22 32 30
III 14 30 35 25 9 33 28 26
IV 7 15 22 16 0 0 11 10
Unknown 0 0 4 3 0 0 9 8
Timing of surgical treatment
Elective 43 93 140 100 18 67* 107 100
Nonelectived 3 7 0 0 9 33 0 0
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days in 2008 (Fig. 1a). Excluding those who underwent
nonelective surgery in 2005 (n = 49), the median time to
treatment was 20 working days. No differences were found
in time to treatment between subgroups of colon cancer
patients in 2005, except for hospital of diagnosis and stage
of disease. The median time to treatment varied substan-
tially among hospitals, ranging from 5 to 28 working days
in 2005. Time to treatment decreased in 2005 with
increasing stage, ranging from 21 working days for stage I
to 4 working days for stage IV. In 2008 similar results were
found, with a significantly longer time to treatment for
patients with a co-morbidity. No differences in time to
treatment were found for colon cancer patients between
2005 and 2008, except for one hospital where the time to
treatment increased from 5 working days in 2005 to 16
working days in 2008 (Table 3).
For patients with rectal cancer, the median time to
preoperative radiotherapy (mainly 5 9 5 Gy) was similar:
Fig. 1 a Time from diagnosis
to start of treatment for colon
cancer patients. b Time from
diagnosis to start of treatment
for rectal cancer patients
undergoing preoperative
radiotherapy. c Time from
diagnosis to start of treatment
for rectal cancer patients with
surgery as the initial treatment
World J Surg
123
28 working days in 2005 and 30 working days in 2008
(Fig. 1b). In 2005 the time to surgery as initial treatment
was 26 working days, whereas it in 2008 was 18 working
days (Fig. 1c). No significant differences were found for
subgroups of patients with rectal cancer who underwent
preoperative radiotherapy in 2005, but there was a signif-
icant difference between hospitals in 2008, ranging from 24
to 38 working days. Furthermore, a significant increase in
time to treatment was found in one hospital. The number of
patients with rectal cancer who did not undergo preopera-
tive radiotherapy was small. However, a significant
decrease in time to treatment was found between 2005 and
2008 for elderly patients (C70 years). Similarly, a reduced
time to treatment for patients with stage I rectal cancer was
found in 2008 compared to that in 2005. For patients with
rectal cancer who underwent preoperative radiotherapy, the
median time from diagnosis to registration at the radio-
therapy institute was 17 working days (5%–95% range: 5–
35 days); and the median time from registration to start of
radiotherapy was 10 working days (5%–95% range: 4–
18 days) in 2005. The median time between start of pre-
operative radiotherapy and surgery was 7 (5%–95% range:
5–67 days) in 2005. Similar time intervals were found for
2008. No significant difference was found in time to
treatment between the two radiotherapy institutes, although
the time to treatment differed by 7 working days between
the two radiotherapy institutes in 2008 (Table 4).
In 2005, imaging procedures for diagnostic purposes of
CRC largely consisted of thoracic radiography and
abdominal US, which were usually conducted 6 to 8
working days after diagnosis. Abdominal and thoracic CT
were used more often for CRC patients in 2008 than in
2005. The use of pelvic MRI increased from 39% in 2005
to 66% in 2008 for patients with rectal cancer (Table 5).
The time from diagnosis to abdominal and/or thoracic CT
was usually 7 working days for CRC patients in 2008,
whereas abdominal US and thoracic radiography were
usually conducted 4 working days after diagnosis in 2008.
In patients with colon cancer, the time to treatment
varied by the symptoms at diagnosis, being around 5
working days (5%–95% range: 0–35 days) for patients
with severe symptoms such as diarrhea, weight loss, and
abdominal pain. Patients with symptoms clustered in the
early-stage cluster had a time to treatment interval of 21
working days (5%–95% range: 0–38 days). A less clear
pattern was found for rectal cancer (data not shown).
The time to treatment was less than 15 working days in
45% of colon cancer patients in 2008, whereas the corre-
sponding figure was 53% in 2005. Preoperative radiother-
apy was given to 4% of rectal cancer patients within 15
working days in both 2005 and 2008. A significantly higher
proportion of rectal cancer patients received initial surgery
within 15 working days (23% vs. 46%; p = 0.04) (Table 6).
Survival analysis showed that a shorter waiting time was
not associated with an improved outcome (data not shown).
After adjusting for tumor stage, differentiation grade, age,
co-morbidity, socioeconomic status, and sex in a multi-
variate proportional hazards regression analysis, this result
did not change (data not shown).
Discussion
The Dutch Cancer Society working group (consisting of
medical specialists, social medicine specialists, and an
economist) proposed in 2005 that the interval between
Table 3 Time from diagnosis to first treatment (in working days):
colon cancer patients
Parameter 2005 2008
No. Median
(5%–95%
range) (days)
No. Median
(5%–95%
range) (days)
Overall 171 13 (0–40) 215 17 (0–43)
Age group
\70 years 71 13 (0–40) 96 15 (0–43)
70 ? years 100 13 (0–40) 119 18 (0–44)
Stage
I 26 21 (9–40) 39 21 (0–44)
II 66 16 (0–35) 75 16 (0–36)
III 51 12 (1–37) 72 18 (0–34)
IV 27 4 (0–32) 22 9 (0–30)
Unknown 1 NA 7 NA
Socioeconomic status
Low 42 13 (0–33) 50 17 (0–44)
Intermediate 59 12 (0–55) 82 21 (0–43)
High 60 15 (0–37) 66 16 (0–43)
Institutionalized 7 14 (0–53) 8 0 (0–28)
Unknown 3 NA 9 18 (0–49)
Co-morbidity
0 70 14 (0-–8) 104 17 (0–43)*
1 51 13 (0–40) 48 17 (0-32)
C2 39 12 (0–40) 54 19 (0–48)
Missing 11 24 (0–76) 9 NA
Hospital stay (days)
1 26 13 (0–31)* 28 13 (0–42)
2 28 12 (0–28) 46 17 (0–34)
3 27 13 (0–70) 28 18 (0–30)
4 37 28 (0–55) 37 20 (0–66)
5 20 6 (0–41) 15 17 (0–60)
6 33 5 (0–27) 61 16 (0–43)**
* p \ 0.05 between hospitals in 2005; ** p = 0.02 between 2005 and
2008
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Table 4 Time from diagnosis to first treatment (in working days): rectal cancer patients
Parameter 2005 2008
No preopRT PreopRT No preopRT PreopRT
No. Median (5%–95%
range) (days)
No. Median (5%–95%
range) (days)
No. Median (5%–95%
range) (days)
No. Median (5%–95%
range) (days)
Overall 41 26 (0–76) 125 28 (15–53) 26 18 (0–68) 95 30 (13–52)
Age group
\70 years 20 19 (0–61) 52 30 (16–62) 9 29 (0–37) 60 30 (16–52)
70? years 21 32 (11–79) 73 25 (15–80) 17 10 (0–98)** 35 29 (16–59)
Stage
I 13 33 (0–97) 38 30 (19–60) 11 13 (0–37)** 23 32 (19–52)
II 8 27 (0–36) 33 28 (15–95) 6 22 (0–98) 30 29 (20–47)
III 13 24 (0–76) 29 24 (13–43) 9 19 (0–68) 25 28 (16–47)
IV 7 15 (5–26) 21 31 (14–61) 0 NA 9 37 (13–113)
Unknown 0 NA 4 NA 0 NA 8 29 (8–46)
Socioeconomic status
Low 7 31 (0–97) 28 29 (16–84) 6 NA 21 28 (16-59)
Intermediate 11 26 (5–47) 46 30 (13–60) 5 41 32 (20–47)
High 17 19 (0–81) 44 26 (18–45) 11 31 28 (19–45)
Institutionalized 5 NA 5 NA 2 1 NA
Missing 1 NA 0 NA 2 0 NA
Co-morbidity
0 25 25 (0-–1) 62 28 (16–47) 12 13 (0–98) 52 30 (16–50)
1 10 33 (0–76) 38 31 (16–62) 7 19 (0–36) 19 30 (7–113)
C2 5 NA 17 27 (14–84) 7 28 (0–68) 20 32 (20–69)
Missing 1 NA 8 29 (13–220) 0 4 NA
Hospital stay (days)
1 6 30 (6–76) 24 24 (12–38) 2 NA 17 24 (11–44)*
2 6 23 (0–31) 15 36 (17–62) 6 15 30 (7–113)
3 2 NA 30 29 (15–60) 5 11 25 (16–59)
4 1 NA 24 30 (16–84) 1 14 29 (8–42)
5 14 35 (19–81) 17 31 (20–80) 4 11 28 (20–52)
6 12 20 (0–47) 15 23 (13–130) 8 27 38 (24–79)**
Radiotherapy institute
1 – – 45 30 (17–53) – – 51 32 (20–52)
2 – – 77 27 (14–60) – – 44 25 (13–52)
* p \ 0.05 between hospitals in 2008; ** p \ 0.05 between 2005 and 2008
Table 5 Percentages of CT and MRI diagnostic imaging in colon and
rectal cancer patients
Parameter 2005 (%) 2008 (%)
Colon
Abdominal CT 49 68
Thoracic CT 14 26
Rectum
Abdominal CT 61 75
Thoracic CT 20 46
Pelvic MRI 39 66
Table 6 Percentage of patients in whom treatment was started in
time according to Dutch Cancer Society advice (\ 15 working days)
Patient conditions 2005 (%) 2008 (%)
Colon cancer 53 45
Rectal cancer without preoperative
radiotherapy
23 46*
Rectal cancer with preoperative
radiotherapy
4 4
* p \ 0.05
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diagnosis and treatment of cancer should be less than 15
working days [5]. Based on our results from 2008, we can
conclude that this advice seems far from feasible to adhere
to in the southern Netherlands; 45% of colon cancer
patients, 46% of rectal cancer patients with surgery as their
initial treatment, and only 4% of patients with rectal cancer
who underwent preoperative radiotherapy were treated
within 15 working days in 2008. No shortening of the
interval from diagnosis to treatment was seen between
2005 and 2008. Moreover, there was substantial variation
in time to treatment among hospitals.
Little is published about time to treatment of CRC
patients after diagnosis. However, in Denmark the median
time interval from diagnosis to treatment was 9 days for
colon cancer patients and 15 days for rectal cancer patients
[6]. The Danish fast-track recommendations, introduced in
1998, stated that the time interval between diagnosis and
treatment should be less than 14 days. In a large popula-
tion-based study of CRC patients diagnosed during 2001–
2002, these recommendations were poorly met; 79% of the
colon cancer patients and 47% of rectal cancer patients
started treatment within 14 days after diagnosis [6]. The
UK government decided that from July 2000 all patients
suspected by their general practitioner to have bowel can-
cer should be seen by a specialist within 2 weeks of the
date of referral [18]. Although cancer patients referred to a
2-week standard clinic were seen more quickly, it did not
reduce the overall time to treatment or stage of disease at
surgery [19]. It is a good initiative to diagnose patients
quickly, but it should be expanded to treatment to reduce
the interval from diagnosis to start of treatment.
Although in recent years much attention has been paid
to reducing the time to treatment in hospitals in The
Netherlands, a shortening in time to treatment between
2005 and 2008 could not be observed. To decrease the
interval between diagnosis and treatment, a project called
Sneller Beter (Getting Well Faster) was started in
November 2003 in The Netherlands funded by the Min-
istry of Health [8]. One of the results of this project was a
reduction of 30 days (from 69 to 39 days) between first
visit to the hospital and start of treatment, usually due to
more efficient process reorganization [20]. In October
2004 two hospitals included in our study engaged in this
project, which indeed resulted in quicker start of surgical
treatment of colon cancer patients in 2005 compared to
other hospitals in southern Netherlands. However, the
advantage of these two hospitals had diminished in 2008.
Another initiative to reduce time to treatment for CRC
patients was the advice by the Dutch Cancer Society
working group, which proposed in 2005 that all patients
with cancer be treated within 15 working days. Therefore,
we expected a decrease in time to treatment between 2005
and 2008. A possible explanation for the lack of
improvement is the increased incidence of CRC and the
probably more severe and complicated co-morbidities of
the patients, which need to be managed before treatment
can be started.
Imaging procedures for diagnostic assessment changed
from largely abdominal US and thoracic radiography in
2005 to abdominal CT and thoracic radiography or thoracic
CT in 2008. In addition, pelvic MRI was indicated for
patients with rectal cancer in 2008. However, the results of
our study indicate that it is unlikely that these changes are
responsible for the lack of reduction in time to treatment;
moreover, the waiting time for a CT scan was similar to the
waiting time for abdominal US and thoracic radiography in
2005.
Most patients with CRC diagnosed in 2005 or 2008 in
southern Netherlands, especially those with rectal cancer,
did not receive treatment within 15 working days. This can
be attributed mainly to hospital factors, including logistics
and multidisciplinary consultation. There are no quantita-
tive data about the influence of delay on prognosis in the
literature. The interpretation of different studies regarding
the association between delay and prognosis is hampered
by factors such as tumor stage and differentiation as well as
patient priority [9]. Therefore, it is controversial to what
degree the time to treatment contributes to stage of disease
and therefore prognosis [9].
We did not find a positive association between a short
time interval from diagnosis to treatment and survival.
Therefore, it can be assumed that other factors not
addressed in this analysis—such as priority of a patient for
start of treatment—are more important for survival than
time to treatment. However, this does not mean that time to
treatment is not important for the patients. CRC is a life-
threatening disease, and a long time interval from diagnosis
to treatment might cause enormous stress for cancer
patients. Such stress can result in deterioration of the
patient’s health, condition, and well-being [10, 11], which
may affect his or her physical condition, in turn resulting in
more complications and a longer hospital stay. Therefore,
reducing time to treatment can reduce health care costs.
Furthermore, patients are generally more satisfied when
they are treated soon after being diagnosed, which results
in a better working environment for health care workers
and increases the quality of the overall health care system.
In addition, based on tumor biology it is important to keep
time to treatment as short as possible. It can be assumed
that in a large proportion of patients a long time to treat-
ment results in deterioration of the prognosis. Therefore,
the time from diagnosis to treatment should be minimized.
It seems far from feasible to follow exactly the current
advice of the Dutch Cancer Society in most of our CRC
patients. Therefore, we propose new advice based on the
general guidelines for time to treatment in Dutch
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specialized care and the results of this study. Guidelines in
Dutch specialized care reveal a time to treatment from
diagnosis to start of clinical treatment within 35 days for
80% of patients and within 49 days for all patients [4].
Cancer patients, however, suffer from a life-threatening
disease and should definitely be treated within this time.
Moreover, they experience a lot of stress and uncertainty
during the time to treatment. Therefore, we propose that the
time from diagnosis to start of treatment should be an
interval of less than 20 working days. According to this
rule, 58% of colon cancer patients, 50% of rectal cancer
patients with surgery as their initial treatment, and 9% of
rectal cancer patients who will undergo preoperative
radiotherapy can meet the advised conditions.
Based on our results, there seems to be no reduction in
time to treatment for patients with CRC in southern Neth-
erlands between 2005 and 2008. Attention and effort should
be paid to reducing time to treatment, which is especially
valuable in view of the increasing proportion of patients
with CRC due to the aging population and the introduction
of population mass screening for CRC in the near future.
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